POLH (DNA polymerase eta) variants and mutations
POLH (also known as DNA polymerase eta) is a human protein-coding gene encoding a DNA polymerase eta protein. DNA polymerase eta bypasses UV-induced DNA lesions during translesion synthesis. Deficiency causes the variant form of xeroderma pigmentosum. This analysis covers 937 POLH variants and mutations. Of these, 97% have computational variant effect predictions. Disease context includes xeroderma pigmentosum variant type, Jaberi-Elahi syndrome, and xeroderma pigmentosum. Example POLH variants include A2T, A2A, and T3A.
Variant analysis overview
- Gene: POLH
- Protein: DNA polymerase eta
- UniProt accession: Q9Y253
- Organism: Homo sapiens
- Variants analyzed: 937
- Variant scope: all variants
- Completed: 2026-10-09
Variant and mutation evidence
- Variant composition: 761 unspecified-consequence records; 106 missense variants; 90 synonymous variants; 7 stop-gained variants; 16 frameshift variants; 2 in-frame deletions; 2 splice-region variants; 3 substitution
- Prediction scores: 905 variants have prediction scores (97% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: xeroderma pigmentosum variant type, Jaberi-Elahi syndrome, xeroderma pigmentosum, hereditary disease, disease of peritoneum, Intellectual disability, breast cancer, hepatocellular carcinoma, acute myeloid leukemia, breast carcinoma, neoplasm, autosomal recessive hypohidrotic ectodermal dysplasia.
Protein structure and variant hotspots
- Protein features: 1 domains; 17 binding sites.
- Structural context: 481 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Diseases linked to POLH
Notable POLH variants
Examples include A2T, A2A, T3A, T3P, T3I, T3T, G4E, G4G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD 6-43582323-G-A, REVEL 0.05, ESM-1b 0.51
- A2A (p.Ala2Ala), gnomAD 6-43582325-T-C, CADD 10.40
- T3A (p.Thr3Ala), rs1368911954, ClinGen CA364272267, ClinVar RCV001162326, TOPMed rs1368911954, REVEL 0.03, ESM-1b 0.00, Uncertain significance, Xeroderma pigmentosum variant type
- T3P (p.Thr3Pro), gnomAD 6-43582326-A-C, REVEL 0.02, ESM-1b 0.00
- T3I (p.Thr3Ile), gnomAD 6-43582327-C-T, REVEL 0.05, ESM-1b 0.16
- T3T (p.Thr3Thr), gnomAD 6-43582328-T-A, CADD 9.12
- G4E (p.Gly4Glu), Ensembl rs1764371869, ESM-1b 0.00, AlphaMissense 0.22
- G4G (p.Gly4Gly), gnomAD 6-43582331-A-G, CADD 12.90
- Q5E (p.Gln5Glu), gnomAD rs532583227, REVEL 0.08, ESM-1b 0.00
- Q5R (p.Gln5Arg), TOPMed rs1764372481, ESM-1b 0.00, AlphaMissense 0.07
- Q5* (p.Gln5Ter), gnomAD 6-43582332-C-T, CADD 36.00
- Q5K (p.Gln5Lys), gnomAD 6-43582332-C-A, REVEL 0.08, ESM-1b 0.61
- D6N (p.Asp6Asn), gnomAD rs1246593709, REVEL 0.10, ESM-1b 0.00
- R7* (p.Arg7Ter), rs1422041536, NCI-TCGA Cosmic COSV6477, cosmic curated COSV64779, TOPMed rs1422041536, CADD 36.00, Likely pathogenic
- R7G (p.Arg7Gly), TOPMed rs1422041536, gnomAD rs1422041536, REVEL 0.79, ESM-1b 1.00, Likely pathogenic
- R7P (p.Arg7Pro), TOPMed rs1446542886, gnomAD rs1446542886, REVEL 0.88, ESM-1b 1.00
- R7Q (p.Arg7Gln), TOPMed rs1446542886, gnomAD rs1446542886, REVEL 0.80, ESM-1b 1.00
- V8G (p.Val8Gly), Ensembl rs1764374380, REVEL 0.75, ESM-1b 1.00
- V8L (p.Val8Leu), gnomAD 6-43582341-G-C, REVEL 0.52, ESM-1b 1.00
- V8V (p.Val8Val), rs757358672, gnomAD 6-43582343-G-T, CADD 8.94
- V9F (p.Val9Phe), rs781288440, ClinGen CA3826861, ClinVar RCV001162327, ExAC rs781288440, REVEL 0.62, ESM-1b 1.00, Uncertain significance, Xeroderma pigmentosum variant type
- V9L (p.Val9Leu), ExAC rs781288440, TOPMed rs781288440, gnomAD rs781288440, REVEL 0.47, ESM-1b 1.00, Uncertain significance
- A10T (p.Ala10Thr), gnomAD 6-43582347-G-A, REVEL 0.46, ESM-1b 1.00
- A10D (p.Ala10Asp), gnomAD 6-43582348-C-A, REVEL 0.81, ESM-1b 1.00
- A10A (p.Ala10Ala), gnomAD 6-43582349-T-C, CADD 12.20
- L11V (p.Leu11Val), ExAC rs745934083, gnomAD rs745934083, REVEL 0.59, ESM-1b 1.00
- L11L (p.Leu11Leu), rs993181321, gnomAD 6-43582352-C-T, CADD 6.49
- V12G (p.Val12Gly), gnomAD rs1764376186, REVEL 0.85, ESM-1b 1.00
- V12L (p.Val12Leu), rs552779831, ClinGen CA364272452, ClinVar RCV001162328, Ensembl rs552779831, ESM-1b 1.00, AlphaMissense 0.38, Uncertain significance, Xeroderma pigmentosum variant type
- V12M (p.Val12Met), cosmic curated COSV10467, Ensembl rs552779831, REVEL 0.75, ESM-1b 1.00, Uncertain significance
- V12V (p.Val12Val), gnomAD 6-43582355-G-A, CADD 9.95
- D13D (p.Asp13Asp), gnomAD 6-43582358-C-T, CADD 11.20
- M14V (p.Met14Val), cosmic curated COSV64779, 1000Genomes rs61748656, ExAC rs61748656, TOPMed rs61748656, REVEL 0.85, ESM-1b 1.00
- D15Y (p.Asp15Tyr), TOPMed rs1430374606, gnomAD rs1430374606, REVEL 0.96, ESM-1b 1.00
- D15H (p.Asp15His), gnomAD 6-43582362-G-C, REVEL 0.97, ESM-1b 1.00
- D15G (p.Asp15Gly), gnomAD 6-43582363-A-G, REVEL 0.96, ESM-1b 1.00
- C16Y (p.Cys16Tyr), ExAC rs780033894, gnomAD rs780033894, REVEL 0.74, ESM-1b 1.00
- C16F (p.Cys16Phe), rs1470766623, gnomAD 6-43582364-CTG-C, CADD 31.00
- F17S (p.Phe17Ser), 1000Genomes rs551454266, ExAC rs551454266, TOPMed rs551454266, gnomAD rs551454266, REVEL 0.94, ESM-1b 1.00
- V19C (p.Val19Cys), rs1308019449, gnomAD 6-43582366-G-GT, CADD 32.00
- V19V (p.Val19Val), rs768525203, gnomAD 6-43582376-T-C, CADD 9.65
- Q20* (p.Gln20Ter), gnomAD rs1319648984
- Q20K (p.Gln20Lys), gnomAD rs1319648984, REVEL 0.76, ESM-1b 1.00
- V21V (p.Val21Val), gnomAD 6-43582382-G-A, CADD 11.70
- E22K (p.Glu22Lys), TOPMed rs1211647469, ESM-1b 1.00, AlphaMissense 0.91
- E22Q (p.Glu22Gln), TOPMed rs1211647469, ESM-1b 1.00, AlphaMissense 0.75
- E22* (p.Glu22Ter), gnomAD 6-43582383-G-T, CADD 37.00
- E22A (p.Glu22Ala), gnomAD 6-43582384-A-C, REVEL 0.92, ESM-1b 1.00
- E22E (p.Glu22Glu), gnomAD 6-43582385-G-A, CADD 4.64
- Q23* (p.Gln23Ter), TOPMed rs1764378104
- R24Q (p.Arg24Gln), Ensembl rs1321149114, REVEL 0.64, ESM-1b 1.00
- R24W (p.Arg24Trp), NCI-TCGA Cosmic COSV6478, cosmic curated COSV64781, Ensembl rs2127773135, REVEL 0.72, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- Q25E (p.Gln25Glu), gnomAD rs1343571221, REVEL 0.09, ESM-1b 0.00
- N26N (p.Asn26Asn), rs774180461, gnomAD 6-43582397-T-C, CADD 10.10
- P27L (p.Pro27Leu), ESP rs376606785, ExAC rs376606785, gnomAD rs376606785, ESM-1b 1.00, AlphaMissense 0.20
- P27S (p.Pro27Ser), ExAC rs761601636, gnomAD rs761601636, REVEL 0.81, ESM-1b 1.00
- P27T (p.Pro27Thr), gnomAD 6-43582398-C-A, REVEL 0.91, ESM-1b 1.00
- P27R (p.Pro27Arg), gnomAD 6-43582399-C-G, REVEL 0.85, ESM-1b 1.00
- H28Y (p.His28Tyr), gnomAD 6-43582401-C-T, REVEL 0.29, ESM-1b 0.62
- H28R (p.His28Arg), gnomAD 6-43582402-A-G, REVEL 0.18, ESM-1b 0.01
- H28H (p.His28His), gnomAD 6-43582403-T-C, CADD 9.05
- L29M (p.Leu29Met), ExAC rs772656490, gnomAD rs772656490, REVEL 0.69, ESM-1b 0.05
- R30G (p.Arg30Gly), ExAC rs760230871, TOPMed rs760230871, gnomAD rs760230871, REVEL 0.72, ESM-1b 1.00, Likely benign
- R30S (p.Arg30Ser), ESP rs368375817, ExAC rs368375817, TOPMed rs368375817, gnomAD rs368375817, REVEL 0.54, ESM-1b 1.00
- R30R (p.Arg30Arg), rs760230871, gnomAD 6-43582407-A-C, CADD 13.40
- R30K (p.Arg30Lys), gnomAD 6-43582408-G-A, REVEL 0.14, ESM-1b 0.00
- N31N (p.Asn31Asn), rs1243247922, gnomAD 6-43582412-T-C, CADD 11.10
- P33L (p.Pro33Leu), Ensembl rs1764380286, ESM-1b 1.00, AlphaMissense 0.84
- P33R (p.Pro33Arg), Ensembl rs1764380286, ESM-1b 1.00, AlphaMissense 0.92
- P33S (p.Pro33Ser), ExAC rs753188996, TOPMed rs753188996, gnomAD rs753188996, REVEL 0.90, ESM-1b 1.00
- C34W (p.Cys34Trp), ESP rs371810027, TOPMed rs371810027, ESM-1b 1.00, AlphaMissense 0.95, Likely benign
- A35V (p.Ala35Val), rs569809153, ClinGen CA3826874, cosmic curated COSV64779, ClinVar RCV000913815, REVEL 0.27, ESM-1b 1.00, Conflicting interpretations, not provided; Inborn genetic diseases
- A35E (p.Ala35Glu), gnomAD 6-43582422-GC-G, CADD 33.00
- A35G (p.Ala35Gly), gnomAD 6-43582423-C-G, REVEL 0.52, ESM-1b 1.00
- A35A (p.Ala35Ala), gnomAD 6-43582424-A-G, CADD 11.70
- V36N (p.Val36Asn), rs2127773185, ClinGen CA450292384, ClinVar RCV000006242, ClinVar RCV005089189, ESM-1b 1.00, AlphaMissense 0.99, Pathogenic
- V36I (p.Val36Ile), gnomAD 6-43582425-G-A, REVEL 0.51, ESM-1b 1.00
- V36L (p.Val36Leu), gnomAD 6-43582425-G-C, REVEL 0.89, ESM-1b 1.00
- V36A (p.Val36Ala), gnomAD 6-43582426-T-C, REVEL 0.87, ESM-1b 1.00
- V36V (p.Val36Val), rs766284431, gnomAD 6-43582427-T-C, CADD 8.36
- V37del (p.Val37del), rs1298773264, gnomAD 6-43582424-AGTT-A, CADD 20.60
- V37I (p.Val37Ile), gnomAD 6-43582428-G-A, REVEL 0.39, ESM-1b 1.00
- Q38E (p.Gln38Glu), rs2127773194, ClinGen CA364273016, ClinVar RCV002258727, Ensembl rs2127773194, REVEL 0.70, ESM-1b 1.00, Uncertain significance, Xeroderma pigmentosum
- Q38Q (p.Gln38Gln), rs112203631, gnomAD 6-43582433-G-A, CADD 9.49
- Y39C (p.Tyr39Cys), ExAC rs751889218, TOPMed rs751889218, gnomAD rs751889218, REVEL 0.77, ESM-1b 1.00
- K40Q (p.Lys40Gln), TOPMed rs1315788120, REVEL 0.29, ESM-1b 1.00
- K40K (p.Lys40Lys), gnomAD 6-43582439-A-G, CADD 11.10
- S41P (p.Ser41Pro), gnomAD 6-43582440-T-C, REVEL 0.30, ESM-1b 0.18
- S41T (p.Ser41Thr), gnomAD 6-43582440-T-A, REVEL 0.15, ESM-1b 0.00
- S41S (p.Ser41Ser), rs757516219, gnomAD 6-43582442-A-T, CADD 11.90
- W42C (p.Trp42Cys), ExAC rs374515054, gnomAD rs374515054, REVEL 0.65, ESM-1b 1.00
- W42* (p.Trp42Ter), gnomAD 6-43582444-G-A, CADD 38.00
- K43* (p.Lys43Ter), ExAC rs750532920, TOPMed rs750532920, gnomAD rs750532920, CADD 40.00
- K43E (p.Lys43Glu), ExAC rs750532920, TOPMed rs750532920, gnomAD rs750532920, REVEL 0.22, ESM-1b 1.00
- K43K (p.Lys43Lys), gnomAD 6-43582448-G-A, CADD 9.33
- G44S (p.Gly44Ser), gnomAD rs1362872500, REVEL 0.66, ESM-1b 1.00
- G44D (p.Gly44Asp), gnomAD 6-43582450-G-A, REVEL 0.67, ESM-1b 1.00
- G45D (p.Gly45Asp), rs2127773221, ClinGen CA364273118, ClinVar RCV002259287, Ensembl rs2127773221, ESM-1b 1.00, AlphaMissense 0.95, Uncertain significance, Xeroderma pigmentosum
- G45R (p.Gly45Arg), ExAC rs756148837, TOPMed rs756148837, gnomAD rs756148837, ESM-1b 1.00, AlphaMissense 0.92, Uncertain significance
- G45S (p.Gly45Ser), cosmic curated COSV64780, ExAC rs756148837, TOPMed rs756148837, gnomAD rs756148837, REVEL 0.72, ESM-1b 1.00, Uncertain significance, Xeroderma pigmentosum variant type
- G45V (p.Gly45Val), gnomAD 6-43582451-TG-T, CADD 32.00
- G45C (p.Gly45Cys), gnomAD 6-43582452-G-T, REVEL 0.86, ESM-1b 1.00
- G46A (p.Gly46Ala), gnomAD 6-43582456-G-C, REVEL 0.59, ESM-1b 1.00
- A49E (p.Ala49Glu), Ensembl rs1764457135, ESM-1b 1.00, AlphaMissense 0.99, Uncertain significance
- A49S (p.Ala49Ser), ExAC rs774751759, gnomAD rs774751759, ESM-1b 1.00, AlphaMissense 0.21
- A49V (p.Ala49Val), rs1764457135, ClinGen CA364274500, ClinVar RCV004512223, ESM-1b 1.00, AlphaMissense 0.99, Uncertain significance, Inborn genetic diseases
- V50G (p.Val50Gly), gnomAD rs1764457268, REVEL 0.82, ESM-1b 1.00
- S51E (p.Ser51Glu), rs752080248, gnomAD 6-43583017-G-GT, CADD 33.00
- S51T (p.Ser51Thr), gnomAD 6-43583021-G-C, REVEL 0.61, ESM-1b 1.00
- S51S (p.Ser51Ser), rs1403127289, gnomAD 6-43583022-T-C, CADD 12.50
- Y52Y (p.Tyr52Tyr), rs762156627, gnomAD 6-43583025-T-C, CADD 8.03
- E53K (p.Glu53Lys), TOPMed rs1764457980, ESM-1b 1.00, AlphaMissense 0.69
- A54A (p.Ala54Ala), rs1582271903, gnomAD 6-43583031-T-G, CADD 9.28
- R55C (p.Arg55Cys), rs1392899966, TOPMed rs1392899966, gnomAD rs1392899966, REVEL 0.73, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R55H (p.Arg55His), ExAC rs767635175, TOPMed rs767635175, gnomAD rs767635175, REVEL 0.80, ESM-1b 1.00
- R55L (p.Arg55Leu), gnomAD 6-43583033-G-T, REVEL 0.82, ESM-1b 1.00
- R55R (p.Arg55Arg), rs749096701, gnomAD 6-43583034-T-C, CADD 11.10
- A56T (p.Ala56Thr), Ensembl rs1561897575, REVEL 0.45, ESM-1b 1.00
- A56A (p.Ala56Ala), rs1245348611, gnomAD 6-43583037-A-T, CADD 11.80
- F57I (p.Phe57Ile), TOPMed rs1764459159, gnomAD rs1764459159, REVEL 0.55, ESM-1b 1.00
- F57S (p.Phe57Ser), rs1561897585, gnomAD 6-43583035-G-GCGT, CADD 31.00
- F57L (p.Phe57Leu), gnomAD 6-43583038-T-C, REVEL 0.32, ESM-1b 0.35
- G58R (p.Gly58Arg), gnomAD rs1315735559, REVEL 0.75, ESM-1b 1.00
- G58V (p.Gly58Val), cosmic curated COSV64780, ExAC rs756182088, gnomAD rs756182088, REVEL 0.83, ESM-1b 1.00
- G58G (p.Gly58Gly), rs766522721, gnomAD 6-43583043-A-G, CADD 10.30
- V59I (p.Val59Ile), cosmic curated COSV10094, ExAC rs753949826, gnomAD rs753949826, REVEL 0.37, ESM-1b 0.00
- T60A (p.Thr60Ala), gnomAD 6-43583047-A-G, REVEL 0.23, ESM-1b 1.00
- T60S (p.Thr60Ser), gnomAD 6-43583048-C-G, REVEL 0.32, ESM-1b 0.05
- R61K (p.Arg61Lys), ExAC rs755024494, gnomAD rs755024494, ESM-1b 1.00, AlphaMissense 0.30
- R61R (p.Arg61Arg), gnomAD 6-43583052-A-G, CADD 13.70
- R61S (p.Arg61Ser), gnomAD 6-43583052-A-T, REVEL 0.51, ESM-1b 1.00
- S62R (p.Ser62Arg), TOPMed rs1296758730, gnomAD rs1296758730, REVEL 0.17, ESM-1b 1.00
- M63I (p.Met63Ile), rs946206811, TOPMed rs946206811, gnomAD rs946206811, ClinGen CA364274724, ESM-1b 1.00, AlphaMissense 0.77, Uncertain significance, Xeroderma pigmentosum variant type
- M63R (p.Met63Arg), ExAC rs778989527, gnomAD rs778989527, ESM-1b 1.00, AlphaMissense 0.70
- M63T (p.Met63Thr), ExAC rs778989527, gnomAD rs778989527, ESM-1b 1.00, AlphaMissense 0.73
- W64R (p.Trp64Arg), TOPMed rs1360464485, gnomAD rs1360464485, REVEL 0.38, ESM-1b 0.00
- W64* (p.Trp64Ter), gnomAD 6-43583061-G-A, CADD 36.00
- A65T (p.Ala65Thr), gnomAD 6-43583062-G-A, REVEL 0.42, ESM-1b 1.00
- A65E (p.Ala65Glu), gnomAD 6-43583063-C-A, REVEL 0.49, ESM-1b 1.00
- A65V (p.Ala65Val), gnomAD 6-43583063-C-T, REVEL 0.38, ESM-1b 0.91
- D66G (p.Asp66Gly), TOPMed rs1240951682, gnomAD rs1240951682, REVEL 0.49, ESM-1b 1.00
- D66N (p.Asp66Asn), gnomAD 6-43583065-G-A, REVEL 0.34, ESM-1b 1.00
- D66A (p.Asp66Ala), gnomAD 6-43583066-A-C, REVEL 0.47, ESM-1b 1.00
- D66D (p.Asp66Asp), gnomAD 6-43583067-T-C, CADD 11.40
- D67G (p.Asp67Gly), gnomAD 6-43583069-A-G, REVEL 0.75, ESM-1b 1.00
- D67E (p.Asp67Glu), gnomAD 6-43583070-T-A, REVEL 0.13, ESM-1b 0.00
- A68T (p.Ala68Thr), Ensembl rs1764460994, ESM-1b 1.00, AlphaMissense 0.81
- A68V (p.Ala68Val), gnomAD 6-43583072-C-T, REVEL 0.67, ESM-1b 1.00
- K69R (p.Lys69Arg), gnomAD 6-43583075-A-G, REVEL 0.20, ESM-1b 0.28
- K69N (p.Lys69Asn), gnomAD 6-43583076-G-C, REVEL 0.53, ESM-1b 1.00
- K70N (p.Lys70Asn), rs149295738, ClinGen CA3826906, ClinVar RCV002259289, ClinVar RCV004958508, REVEL 0.39, ESM-1b 1.00, Uncertain significance, Xeroderma pigmentosum; Inborn genetic diseases
- K70R (p.Lys70Arg), TOPMed rs1764461301, ESM-1b 0.00, AlphaMissense 0.08
- K70S (p.Lys70Ser), rs1176350430, gnomAD 6-43583075-AG-A, CADD 31.00
- K70T (p.Lys70Thr), gnomAD 6-43583078-A-C, REVEL 0.55, ESM-1b 0.00
- L71Y (p.Leu71Tyr), gnomAD 6-43583079-GT-G, CADD 25.30
- L71S (p.Leu71Ser), gnomAD 6-43583081-T-C, REVEL 0.71, ESM-1b 1.00
- C72R (p.Cys72Arg), cosmic curated COSV10592, ExAC rs758211914, TOPMed rs758211914, gnomAD rs758211914, REVEL 0.81, ESM-1b 1.00
- P73R (p.Pro73Arg), TOPMed rs1764461980, gnomAD rs1764461980, REVEL 0.68, ESM-1b 1.00
- P73T (p.Pro73Thr), ExAC rs777311808, gnomAD rs777311808, REVEL 0.65, ESM-1b 1.00
- L75F (p.Leu75Phe), gnomAD rs1169717855, REVEL 0.58, ESM-1b 1.00
- L75S (p.Leu75Ser), gnomAD 6-43583090-A-AT, CADD 29.60
- L76P (p.Leu76Pro), TOPMed rs1183777159, gnomAD rs1183777159, REVEL 0.55, ESM-1b 0.67
- L76L (p.Leu76Leu), gnomAD 6-43583095-C-T, CADD 12.70
- L77del (p.Leu77del), rs1426687865, gnomAD 6-43583090-ATCT-A, CADD 20.00
- L77L (p.Leu77Leu), rs199840329, gnomAD 6-43583098-C-T, CADD 11.20
- A78T (p.Ala78Thr), rs372613817, ClinGen CA3826910, ClinVar RCV000304368, ESP rs372613817, REVEL 0.33, ESM-1b 1.00, Conflicting interpretations, Xeroderma pigmentosum variant type
- A78S (p.Ala78Ser), gnomAD 6-43583101-G-T, REVEL 0.41, ESM-1b 0.57
- A78A (p.Ala78Ala), gnomAD 6-43583103-A-C, CADD 13.10
- Q79K (p.Gln79Lys), gnomAD rs1334379506, REVEL 0.17, ESM-1b 1.00
- Q79Q (p.Gln79Gln), rs1175199526, gnomAD 6-43583106-A-G, CADD 16.80
- V80I (p.Val80Ile), gnomAD 6-43583107-G-A, REVEL 0.37, ESM-1b 1.00
- R81C (p.Arg81Cys), rs113074920, cosmic curated COSV64779, ESP rs113074920, ExAC rs113074920, REVEL 0.45, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R81G (p.Arg81Gly), ESP rs113074920, ExAC rs113074920, TOPMed rs113074920, gnomAD rs113074920, ESM-1b 1.00, AlphaMissense 0.13
- R81H (p.Arg81His), ESP rs370219191, ExAC rs370219191, gnomAD rs370219191, REVEL 0.09, ESM-1b 1.00
- R81R (p.Arg81Arg), rs1303520413, gnomAD 6-43583112-T-C, CADD 12.70
- E82D (p.Glu82Asp), 1000Genomes rs77759052, ExAC rs77759052, TOPMed rs77759052, gnomAD rs77759052, REVEL 0.33, ESM-1b 0.65
- E82Q (p.Glu82Gln), gnomAD rs1764464098, REVEL 0.32, ESM-1b 1.00
- S83F (p.Ser83Phe), rs774770256, ClinGen CA3826914, ClinVar RCV001164355, ExAC rs774770256, REVEL 0.20, ESM-1b 0.69, Uncertain significance, Xeroderma pigmentosum variant type
- S83S (p.Ser83Ser), rs1295580401, gnomAD 6-43583118-C-G, CADD 8.62
- R84C (p.Arg84Cys), rs762176747, NCI-TCGA Cosmic COSV1009, cosmic curated COSV10094, REVEL 0.47, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
Public POLH analysis runs
- POLH analysis run — POLH (937 variants) — completed 2026-10-09